These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38592119)

  • 1. The Impact of Anti-Amyloid Immunotherapies on Stroke Care.
    Bilodeau PA; Dickson JR; Kozberg MG
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy.
    DiFrancesco JC; Longoni M; Piazza F
    Front Neurol; 2015; 6():207. PubMed ID: 26441825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.
    Heuer E; Jacobs J; Du R; Wang S; Keifer OP; Cintron AF; Dooyema J; Meng Y; Zhang X; Walker LC
    J Alzheimers Dis; 2017; 57(2):519-530. PubMed ID: 28269776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Amyloid-Related Imaging Abnormalities (ARIA).
    Urbach H; Linn J; Hattingen E; Fiebach J
    Rofo; 2024 Apr; 196(4):363-369. PubMed ID: 37995736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics.
    Hampel H; Elhage A; Cho M; Apostolova LG; Nicoll JAR; Atri A
    Brain; 2023 Nov; 146(11):4414-4424. PubMed ID: 37280110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and Management of Amyloid-Related Imaging Abnormalities in Patients with Alzheimer's Disease Treated with Anti-Amyloid Beta Therapy.
    Barakos J; Purcell D; Suhy J; Chalkias S; Burkett P; Marsica Grassi C; Castrillo-Viguera C; Rubino I; Vijverberg E
    J Prev Alzheimers Dis; 2022; 9(2):211-220. PubMed ID: 35542992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis.
    Arrighi HM; Barakos J; Barkhof F; Tampieri D; Jack C; Melançon D; Morris K; Ketter N; Liu E; Brashear HR
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):106-12. PubMed ID: 25669746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications.
    Doran SJ; Sawyer RP
    Front Neurosci; 2024; 18():1326784. PubMed ID: 38312931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities.
    Söderberg L; Johannesson M; Gkanatsiou E; Nygren P; Fritz N; Zachrisson O; Rachalski A; Svensson AS; Button E; Dentoni G; Osswald G; Lannfelt L; Möller C
    Sci Rep; 2024 May; 14(1):10868. PubMed ID: 38740836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic stroke associated with amyloid-related imaging abnormalities in a patient treated with lecanemab.
    Gibson AW; Elser H; Rosso M; Cornblath EJ; Fonkeu Y; Prasad S; Rothstein A; Nasrallah IM; Wolk DA; Guo MH
    Alzheimers Dement; 2024 Aug; ():. PubMed ID: 39215494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for ARIA Monitoring.
    Cogswell PM; Andrews TJ; Barakos JA; Barkhof F; Bash S; Benayoun MD; Chiang GC; Franceschi AM; Jack CR; Pillai JJ; Poussaint TY; Raji CA; Ramanan VK; Tanabe J; Tanenbaum L; Whitlow CT; Yu FF; Zaharchuk G; Zeinah M; Benzinger TS;
    AJNR Am J Neuroradiol; 2024 Aug; ():. PubMed ID: 39179297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-Related Imaging Abnormalities With Anti-amyloid Antibodies for the Treatment of Dementia Due to Alzheimer's Disease.
    Withington CG; Turner RS
    Front Neurol; 2022; 13():862369. PubMed ID: 35401412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three major effects of APOE
    Foley KE; Wilcock DM
    Front Aging Neurosci; 2024; 16():1412006. PubMed ID: 38756535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-Related Imaging Abnormalities: An Update.
    Roytman M; Mashriqi F; Al-Tawil K; Schulz PE; Zaharchuk G; Benzinger TLS; Franceschi AM
    AJR Am J Roentgenol; 2023 Apr; 220(4):562-574. PubMed ID: 36321981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-related Imaging Abnormalities in Alzheimer Disease Treated with Anti-Amyloid-β Therapy.
    Agarwal A; Gupta V; Brahmbhatt P; Desai A; Vibhute P; Joseph-Mathurin N; Bathla G
    Radiographics; 2023 Sep; 43(9):e230009. PubMed ID: 37651273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Amyloid Therapy, AD, and ARIA: Untangling the Role of CAA.
    Sin MK; Zamrini E; Ahmed A; Nho K; Hajjar I
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid related imaging abnormalities in the emergency setting.
    Czerminski J; Khatri S; Rao B
    Emerg Radiol; 2024 Sep; ():. PubMed ID: 39331307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcortical signal alteration of corticospinal tracts. A radiologic manifestation of ARIA: A case report.
    Sotoudeh H; Alizadeh M; Shahidi R; Shobeiri P; Love N; Singhal A
    Radiol Case Rep; 2023 Jan; 18(1):275-279. PubMed ID: 36388611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects.
    Villain N; Planche V; Levy R
    Rev Neurol (Paris); 2022 Dec; 178(10):1011-1030. PubMed ID: 36184326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.
    Villarreal S; Zhao F; Hyde LA; Holder D; Forest T; Sondey M; Chen X; Sur C; Parker EM; Kennedy ME
    J Alzheimers Dis; 2017; 59(4):1393-1413. PubMed ID: 28800329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.